fbpx
0f9407626e83ba22b

(May 10, 2022) Webinar: Different Modalities to Study Mechanisms of Hemorrhagic Stroke in A Rat Model

Overview: Hemorrhagic stroke occurrence is functionally partially based on the diet, underlying disease states, nutritional availability, and potential presence of chronic inflammatory disease. Dr. Noriko discussed the potential mechanisms of cerebrovascular dysfunction that lead to hemorrhagic stroke, potential physiological alterations, and possible methods of treatment in preclinical studies. The webinar investigated these questions

By |2022-05-11T14:15:13-04:00May 10th, 2022|Categories: Animal Models, Event, In Vitro/Ex Vivo, Past Webinar, Pressure Arteriography, Rat, Wire Myography|Comments Off on (May 10, 2022) Webinar: Different Modalities to Study Mechanisms of Hemorrhagic Stroke in A Rat Model

(March 30, 2022) Webinar: Imaging Hypoxia

Overview: In this webinar, Katie discussed the role hypoxia plays in disease progression and treatment response, specifically in cancer. She also explained the various molecular imaging technologies that can be used to visualize and assess hypoxia in preclinical cancer models. Some modalities that were covered include magnetic resonance imaging (MRI), positron emission tomography

By |2022-03-31T15:50:32-04:00March 31st, 2022|Categories: Cancer Research, Event, Imaging, MRI, Optical, Past Webinar, PET/CT|Comments Off on (March 30, 2022) Webinar: Imaging Hypoxia

Scintica & Trust Bio-sonics

Scintica and Trust Bio-sonics announce exclusive partnership for the distribution of its preclinical USphere™ Series Contrast Agents [January 27, 2022] Scintica is excited to announce its exclusive distribution agreement for North America and Europe with Trust Bio-sonics, a pharmaceutical company and developer of the USphere Series of contrast agents for translational research and medicine

By |2022-01-27T10:51:45-05:00January 27th, 2022|Categories: News|Comments Off on Scintica & Trust Bio-sonics

Myr & Scintica

Scintica and Especialidades Médicas Myr, S.L. announce exclusive partnership for the distribution of its Electromedical Instruments for Anatomical Pathology [January 24, 2022] Scintica is excited to announce its exclusive distribution agreement for Canada with Especialidades Médicas Myr, S.L., developer, and manufacturer of electromedical instruments for anatomical pathology. Myr has over 30 years of experience

By |2022-01-27T10:53:59-05:00January 24th, 2022|Categories: News|Comments Off on Myr & Scintica

Scintica and Aspect Imaging Announce New Extended Partnership

[January 5, 2022] Scintica is excited to announce its new and extended distribution agreement for preclinical products with Aspect Imaging, global leader in innovative, high-performance permanent magnet MRI technology. Aspect imaging has been pushing the boundaries of permanent magnet design to deliver easy-to-use MR imaging solutions for both clinical and preclinical market segments. The

By |2022-01-05T11:46:15-05:00January 5th, 2022|Categories: Event, News|Tags: |Comments Off on Scintica and Aspect Imaging Announce New Extended Partnership
Go to Top